NCT02292745View on ClinicalTrials.gov

Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 2, 2014

Primary Completion Date

May 24, 2018

Study Completion Date

May 24, 2018

Conditions
Pancreatic Neoplasms
Interventions
RADIATION

stereotactic radiotherapy

Trial Locations (1)

3015 CE

Erasmus MC, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

lead

Foundation for Liver Research

OTHER